Entering the agentic era of AI in drug discovery

R. S. K. Vijayan, Jason B. Cross, Vasanthanathan Poongavanam

Open source

DOI
10.1038/s41589-026-02295-x
Published
2026-08-19
Container
Nature Chemical Biology
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41589-026-02295-x,
  title = {Entering the agentic era of AI in drug discovery},
  author = {R. S. K. Vijayan and Jason B. Cross and Vasanthanathan Poongavanam},
  year = {2026},
  journal = {Nature Chemical Biology},
  doi = {10.1038/s41589-026-02295-x},
  url = {https://doi.org/10.1038/s41589-026-02295-x}
}

RIS

TY  - JOUR
TI  - Entering the agentic era of AI in drug discovery
AU  - R. S. K. Vijayan
AU  - Jason B. Cross
AU  - Vasanthanathan Poongavanam
PY  - 2026
JO  - Nature Chemical Biology
DO  - 10.1038/s41589-026-02295-x
UR  - https://doi.org/10.1038/s41589-026-02295-x
ER  - 

APA

Vijayan, R. S. K., Cross, J. B., & Poongavanam, V. (2026). Entering the agentic era of AI in drug discovery. Nature Chemical Biology. https://doi.org/10.1038/s41589-026-02295-x

Source records